Live Breaking News & Updates on Forest Capital Management

Stay updated with breaking news from Forest capital management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Insider Selling: IES Holdings, Inc. (NASDAQ:IESC) CEO Sells 25,000 Shares of Stock

IES Holdings, Inc. (NASDAQ:IESC – Get Free Report) CEO Jeffrey L. Et Al Gendell sold 25,000 shares of the stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $133.18, for a total value of $3,329,500.00. Following the completion of the sale, the chief executive officer now owns […] ....

United-states , Al-gendell , Ies-holdings-inc , Securities-exchange-commission , Acadian-asset-management , Nasdaq , Connor-clark-lunn-investment-management-ltd , Holdings-inc , Company-profile , Janney-montgomery-scott , Get-free-report , Exchange-commission

1,090,576 Shares in HireRight Holdings Co. (NYSE:HRT) Bought by Park West Asset Management LLC

Park West Asset Management LLC acquired a new position in shares of HireRight Holdings Co. (NYSE:HRT – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,090,576 shares of the company’s stock, valued at approximately $14,668,000. HireRight accounts for approximately 1.4% […] ....

New-york , United-states , Ohio , William-blair , Hireright-holdings-corporation , Hireright-company-profile , Exchange-commission , York-state-common-retirement-fund , Park-west-asset-management , Hireright-holdings-co , Needham-company , Jacobs-levy-equity-management-inc

Price T Rowe Associates Inc. MD Boosts Stock Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR)

Price T Rowe Associates Inc. MD grew its position in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 5.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 5,335,712 shares of the company’s stock after purchasing an additional 278,287 shares during the quarter. Price T Rowe Associates Inc. MD owned about 0.10% […] ....

Joanna-horobin , Piper-sandler , Pricet-rowe-associates-inc , Jpmorgan-chase-co , Campbell-co-investment-adviser , Holdings-channel , Wolfe-research , Nasdaq , Kymera-therapeutics-inc , Securities-exchange-commission , Pricet-rowe-associates , Kymera-therapeutics

Bullseye Asset Management LLC Grows Stake in Bowlero Corp. (NYSE:BOWL)

Bullseye Asset Management LLC lifted its stake in Bowlero Corp. (NYSE:BOWL – Free Report) by 39.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 159,940 shares of the company’s stock after buying an additional 45,000 shares during the period. Bullseye Asset Management […] ....

Mexico , United-states , Canada , Switzerland , Swiss , Roth-mkm , Craig-hallum , Bowlero-corp , Teza-capital-management , Swiss-national-bank , Canaccord-genuity-group , Clearstead-advisors

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 12-Month High at $25.59

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as $25.59 and last traded at $25.58, with a volume of 366347 shares changing hands. The stock had previously closed at $25.57. Analysts Set New Price Targets A number of […] ....

United-states , Charles-schwab-investment-management-inc , Deciphera-pharmaceuticals-price-performance , Institutional-trading-of-deciphera-pharmaceuticals , Deciphera-pharmaceuticals , Deciphera-pharmaceuticals-inc , Principal-financial-group-inc , Jefferies-financial-group , Deciphera-pharmaceuticals-company-profile , Deutsche-bank , Jpmorgan-chase-co